Tomoko Toga

408 total citations
19 papers, 340 citations indexed

About

Tomoko Toga is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tomoko Toga has authored 19 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tomoko Toga's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer-related Molecular Pathways (4 papers) and TGF-β signaling in diseases (2 papers). Tomoko Toga is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer-related Molecular Pathways (4 papers) and TGF-β signaling in diseases (2 papers). Tomoko Toga collaborates with scholars based in Japan and Russia. Tomoko Toga's co-authors include Yoshinori Nio, Masayuki Itakura, Kunihiro Yamasawa, Chikage Iguchi, Koji Hashimoto, Ming Dong, Katsuhiro Tamura, Seiji Yano, Makoto Koike and Riruke Maruyama and has published in prestigious journals such as Electrophoresis, Progress in Neuro-Psychopharmacology and Biological Psychiatry and Journal of Surgical Oncology.

In The Last Decade

Tomoko Toga

19 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoko Toga Japan 13 187 155 56 45 40 19 340
Seishi Kimura Japan 9 137 0.7× 182 1.2× 37 0.7× 64 1.4× 36 0.9× 18 394
Sheng-Hong Tseng Taiwan 8 81 0.4× 192 1.2× 27 0.5× 30 0.7× 50 1.3× 12 362
Hiroko Misawa Japan 12 139 0.7× 235 1.5× 53 0.9× 40 0.9× 47 1.2× 17 450
PJ Roberts Finland 9 224 1.2× 154 1.0× 94 1.7× 84 1.9× 34 0.8× 15 428
Seong Whan Jeong South Korea 9 128 0.7× 344 2.2× 26 0.5× 45 1.0× 71 1.8× 12 439
Vincent Roh Switzerland 11 147 0.8× 231 1.5× 27 0.5× 71 1.6× 104 2.6× 15 424
Yue‐Can Zeng China 14 182 1.0× 192 1.2× 26 0.5× 52 1.2× 78 1.9× 29 460
Wing‐Keung Chu Taiwan 10 89 0.5× 162 1.0× 31 0.6× 26 0.6× 55 1.4× 17 351
Akio Shimizu Japan 11 100 0.5× 177 1.1× 35 0.6× 29 0.6× 59 1.5× 24 394
Ali Dadbin United States 8 98 0.5× 192 1.2× 46 0.8× 24 0.5× 73 1.8× 10 355

Countries citing papers authored by Tomoko Toga

Since Specialization
Citations

This map shows the geographic impact of Tomoko Toga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Toga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Toga more than expected).

Fields of papers citing papers by Tomoko Toga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Toga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Toga. The network helps show where Tomoko Toga may publish in the future.

Co-authorship network of co-authors of Tomoko Toga

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Toga. A scholar is included among the top collaborators of Tomoko Toga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Toga. Tomoko Toga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kimura‐Kataoka, Kaori, Toshihiro Yasuda, Junko Fujihara, et al.. (2012). Distribution and haplotype analysis of all the non-synonymous and autoimmunity-related single nucleotide polymorphisms in the human deoxyribonuclease II gene using worldwide populations. Legal Medicine. 15(3). 157–160. 3 indexed citations
2.
Kimura‐Kataoka, Kaori, Toshihiro Yasuda, Junko Fujihara, et al.. (2012). Genetic and expression analysis of SNPs in the human deoxyribonuclease II: SNPs in the promoter region reduce its in vivo activity through decreased promoter activity. Electrophoresis. 33(18). 2852–2858. 16 indexed citations
3.
Iida, Reiko, Junko Fujihara, Toshihiro Yasuda, et al.. (2011). Simultaneous determination of seven informative Y chromosome SNPs to differentiate East Asian, European, and African populations. Legal Medicine. 13(3). 134–141. 10 indexed citations
4.
Fujihara, Junko, Hiroaki Nakamura, Kaori Kimura‐Kataoka, et al.. (2011). Determination of ABO genotypes by real-time PCR using allele-specific primers. Legal Medicine. 14(1). 47–50. 23 indexed citations
5.
Hayashida, Maiko, Tsuyoshi Miyaoka, Keiko Tsuchie, et al.. (2009). Hyperbilirubinemia-related behavioral and neuropathological changes in rats: A possible schizophrenia animal model. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(4). 581–588. 28 indexed citations
6.
Nio, Yoshinori, Chikage Iguchi, Masayuki Itakura, et al.. (2009). High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders.. PubMed. 29(5). 1607–10. 13 indexed citations
7.
Nio, Yoshinori, Tomoko Toga, Riruke Maruyama, & Masakazu Fukushima. (2007). Expression of orotate phosphoribosyl transferase in human pancreatic cancer: Implication for the efficacy of uracil and tegafur-based adjuvant chemotherapy. Oncology Reports. 4 indexed citations
8.
Nio, Yoshinori, Chikage Iguchi, Masayuki Itakura, et al.. (2007). Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase. Oncology Reports. 17(1). 153–9. 7 indexed citations
9.
Nio, Yoshinori, Seiji Yano, Tomoko Toga, et al.. (2006). Immunohistochemical expression of HER-1 and HER-2 in extrahepatic biliary carcinoma.. PubMed. 26(1B). 763–70. 20 indexed citations
10.
Nio, Yoshinori, Koji Hashimoto, Masayuki Itakura, et al.. (2005). Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.. PubMed. 25(5). 3523–9. 10 indexed citations
11.
Toga, Tomoko, Yoshinori Nio, Koji Hashimoto, Tetsuya Higami, & Riruke Maruyama. (2004). The dissociated expression of protein and messenger RNA of DPC4 in human invasive ductal carcinoma of the pancreas and their implication for patient outcome.. PubMed. 24(2C). 1173–8. 15 indexed citations
12.
Dong, Ming, et al.. (2003). p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. Journal of Surgical Oncology. 82(2). 111–120. 36 indexed citations
13.
Nio, Yoshinori, Tomoko Toga, Koji Hashimoto, et al.. (2003). Immunohistochemical expression of receptor-tyrosine kinase c-kit protein in invasive ductal carcinoma of the pancreas. Anti-Cancer Drugs. 14(4). 313–319. 20 indexed citations
14.
Nio, Yoshinori, et al.. (2002). A fractal dimension analysis: a new method for evaluating the response of anticancer therapy.. PubMed. 22(4). 2347–54. 6 indexed citations
15.
Nio, Yoshinori, Ming Dong, Chikage Iguchi, et al.. (2001). Expression of Bcl‐2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: Effects on clinical outcome and efficacy of adjuvant chemotherapy. Journal of Surgical Oncology. 76(3). 188–196. 32 indexed citations
16.
Hashimoto, Koji, Yoshinori Nio, Shoichiro Sumi, et al.. (2001). Correlation Between TGF-β1 and p21 (WAF1/CIP1) Expression and Prognosis in Resectable Invasive Ductal Carcinoma of the Pancreas. Pancreas. 22(4). 341–347. 22 indexed citations
17.
Nio, Yoshinori, Chikage Iguchi, Kunihiro Yamasawa, et al.. (2001). Apoptosis and Expression of Bcl-2 and Bax Proteins in Invasive Ductal Carcinoma of the Pancreas. Pancreas. 22(3). 230–239. 24 indexed citations
18.
Iguchi, Chikage, Yoshinori Nio, Hiroshi Takeda, et al.. (2001). Plant polysaccharide PSK: cytostatic effects on growth and invasion; modulating effect on the expression of HLA and adhesion molecules on human gastric and colonic tumor cell surface.. PubMed. 21(2A). 1007–13. 27 indexed citations
19.
Hirahara, Noriyuki, et al.. (2000). Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.. PubMed. 20(5A). 3293–9. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026